Initiator Pharma: Final Analysis of IPTN2021 Phase I Study - Redeye

Initiator Pharma announced today that the final dataset and analysis had been obtained in the IPTN2021 Phase I trial. Redeye is encouraged to learn that the final analysis confirms the positive efficacy observed in the initial read-out.

Länk till analysen i sin helhet: https://www.redeye.se/research/855998/initiator-pharma-final-analysis-of-iptn2021-phase-i-study?utm_source=finwire&utm_medium=RSS